Development and Validation of a UPLC Method for the Determination of Docetaxel and Its Related Substances in Pharmaceutical Dosage Forms, an Antineoplastic Agent

ISSN Print: 2156-8251
ISSN Online: 2156-8278
www.scirp.net/journal/ajac
E-mail: [email protected]

Citations

"Development and Validation of a UPLC Method for the Determination of Docetaxel and Its Related Substances in Pharmaceutical Dosage Forms, an Antineoplastic Agent"
written by Srinivasulu Kasa, Sreenivas Pippalla, Mopidevi Narasimha Naidu, Dipak Goyal,
published by American Journal of Analytical Chemistry, Vol.15 No.10, 2024

has been cited by the following article(s):

No relevant information.

[1]	Determination of Tyrosine Kinase Inhibitors as Antineoplastic Agents in Pharmaceutical and Biological Matrices: An Overview of Recent Analytical Techniques Chemistry & Biodiversity, 2026 DOI:10.1002/cbdv.202501025

[2]	Impurities in Oncology Pharmaceuticals: A Review of Classification, Detection Methods, Regulatory Frameworks and Emerging Trends Therapeutic Innovation & Regulatory Science, 2026 DOI:10.1007/s43441-026-00948-6

[3]	A Review on Analytical Insights into Impurity Profiling of Selected Anticancer Agents: Tinibs and Taxanes Critical Reviews in Analytical Chemistry, 2026 DOI:10.1080/10408347.2026.2718350